Does Allergan Deal Create New Phase of Pharma M&A?

April 22 (Bloomberg) -- Yale Law School Professor Jonathan Macey and Columbia Business School Professor Fabio Savoldelli dig deeper into the structure of the deal for Allergan by Valeant and activist investor Bill Ackman on Bloomberg Television’s “Market Makers.”

Can ECB's Draghi Exceed Market's QE Expectations?
28:05 - Peter Schaffrik, head of European rates and economics research at RBC Capital Markets, previews this week's European Central Bank decision and discusses his expectations for a move by the Federal Reserve on interest rates. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • Middle East Economies and the Impact of Cheap Oil
  • Can Central Banks Remain Tight in Spite of QE?
  • What Is China's Interest in Middle East Investment?